Since the action of PD-1/PD-L1 inhibitors requires the involvement of lymphocytes in the vicinity of the tumor, the degree of TILs infiltration can also be used as a biomarker to predict the efficacy of PD-1/PD-L1 inhibitors. This evidence concerns the gene CD274 and neoplasm.